Eltero 15mg Tablet 10pcs

✔️ Uses of Eltero 15

Treatment of Type 2 diabetes mellitus

✔️ How does Eltero 15 work?

Ertugliflozin selectively inhibits the sodium-glucose transporter-2 (SGLT2), which decreases the renal threshold for glucose, resulting in increased glucose excretion in urine.

✔️ Side Effects of Eltero 15

• Thrush (fungal infection)
• Pain or a burning feeling when you pee
• Peeing more than normal
• Mild skin rash or itchy skin

✔️ Benefits: Eltero 15

Eltero 15 is essential in managing diabetes by effectively controlling blood sugar levels. It works by delaying sugar absorption and enhancing insulin sensitivity, which helps maintain stable blood glucose levels without causing abrupt drops or significant hypoglycemia.

In cases of prediabetes, Eltero 15 is the only recommended treatment option. Additionally, it plays a crucial role in preventing severe complications associated with diabetes, such as:

• Diabetic Nephropathy: Kidney damage
• Diabetic Retinopathy: Vision loss or blindness
• Diabetic Neuropathy: Loss of sensation in hands and feet, which can lead to serious injuries or foot loss

Moreover, Eltero 15 reduces the risk of cardiovascular events, such as heart attacks and strokes, making it a valuable option for comprehensive diabetes management.

✔️ Administration Guidelines: Eltero 15

• Take once daily in the morning, either with or without food.
• The recommended starting dose is 5 mg orally once daily. If the starting dose is well-tolerated and further glycemic control is required, the dose may be increased to a maximum of 15 mg daily.
• No dosage adjustments are needed for mild to moderate hepatic impairment; however, the drug is not recommended for those with severe hepatic impairment.
• Swallow Ertugliflozin as a whole with water; do not crush, break, or chew it.

✔️ Pediatric Use: Eltero 15

• Children under 18 years: The safety and efficacy of Ertugliflozin in this age group have not been established.

✔️ Renal Considerations: Eltero 15

• For patients with eGFR ≥ 60 mL/min/1.73 m²: No dosage adjustment is necessary.
• For patients with eGFR < 30 mL/min/1.73 m²: The use of Ertugliflozin is contraindicated.
• For those with eGFR 30-60 mL/min/1.73 m²: Initiation is not recommended, and continued use is discouraged if eGFR remains persistently in this range.

✔️ Geriatrics: Eltero 15

• No dosage adjustments based on age; however, elderly patients may be more susceptible to adverse effects related to volume depletion.

✔️ Overdose Management: Eltero 15

In the event of an overdose, contact Poison Control. Supportive care is recommended, but the removal of Ertugliflozin via hemodialysis has not been studied.

✔️ Drug Interactions: Eltero 15

• Increased hypoglycemia risk when used with insulin and insulin secretagogues; dosage adjustments may be necessary.
• Urine glucose tests are not recommended for monitoring glycemic control due to the nature of SGLT2 inhibitors.
• Use alternative methods for monitoring glycemic control.

✔️ Contraindications: Eltero 15

• Hypersensitivity: Known severe allergic reactions.
• Renal Issues: Severe renal impairment, end-stage renal disease, or dialysis.

✔️ Precautions: Eltero 15

• Volume Contraction: This can cause intravascular volume contraction, leading to symptomatic hypotension, especially in patients with renal impairment, low systolic blood pressure, those on diuretics, or older adults.
• Ketoacidosis Risk: There have been reports of ketoacidosis, a serious condition that requires urgent medical attention. Patients should be monitored for risk factors and symptoms of ketoacidosis.
• Renal Impairment: Monitor kidney function before starting and periodically thereafter, especially in patients at risk for acute kidney injury.
• Genital Infections: Increased risk of genital mycotic infections; those with a history are more susceptible.
• Urinary Tract Infections: Higher risk of serious UTIs, including urosepsis and pyelonephritis.

✔️ Pregnancy and Lactation: Eltero 15

• Pregnancy: Due to animal studies indicating potential renal issues, Ertugliflozin is not recommended during the second and third trimesters. Risks associated with poorly controlled diabetes during pregnancy must be considered.
• Lactation: There is insufficient data regarding the drug’s presence in human milk, and due to potential risks to developing kidneys, it is advised against use while breastfeeding.

✔️ Storage Instructions of Eltero 15

Store at or below 30°C in a dry place. Use only under the guidance of a registered physician.